Will loplastin/romilastin fall off if I stop taking it?
Romiplostim/Romiplostim is a drug used to treat immune thrombocytopenia (ITP). Its main function is to promote platelet production by stimulating the thrombopoietic factor receptor (TPO-R). For many patients with ITP, especially those who do not respond well to other treatments, loprostim provides an effective treatment option. However, some patients may worry about whether their platelet count will drop again after stopping treatment.
Generally speaking, if a patient achieves a stable platelet level during treatment with Ropremilast, there is a chance that the platelet count will gradually decrease once the drug is discontinued. The reason is that Roprostim promotes the production of platelets by activating the thrombopoietic factor receptor. Once the drug is stopped, the bone marrow's platelet production response will weaken, and the platelet production rate will return to the level before the drug was used. Therefore, most patients will experience a drop in platelet count after stopping the drug, especially in the early stages of treatment.
However, not all patients immediately return to their original low platelet levels after stopping the drug. For some patients who have long-term use of Roprostim and have achieved a relatively stable therapeutic effect, the platelet count may maintain a certain stability despite no drug intervention. This phenomenon usually occurs as a patient's immune system and bone marrow gradually recover.
The consequences of stopping medication vary from person to person, so patients should be guided by a doctor when stopping medication and avoid stopping medication on their own. In some cases, doctors may choose to gradually reduce the dose of the drug or adjust the frequency of injections to reduce the risk of a sudden drop in platelet counts. In addition, platelet counts may need to be monitored closely after discontinuation of the drug to ensure that the patient's platelet levels do not drop to dangerous levels without drug support.
Reference materials:https://en.wikipedia.org/wiki/Romiplostim
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)